P3.13-35 Antitumor Effect of Neratinib Targeting HER2-Altered Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1876
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeting HER2 Aberrations in Non-Small Cell Lung Cancer With Osimertinib

Clinical Cancer Research
Cancer ResearchOncology
2018English

Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?

Oncology in Clinical Practice
Oncology
2019English

Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer

Cancer immunology research
Cancer ResearchImmunology
2017English

Spectral Fluorescence Molecular Imaging of Lung Metastases Targeting HER2/neu

Clinical Cancer Research
Cancer ResearchOncology
2007English

Antitumor Activity of Phenethyl Isothiocyanate in HER2-positive Breast Cancer Models

BMC Medicine
Medicine
2012English

Perspectives of HER2-targeting in Gastric and Esophageal Cancer

Expert Opinion on Investigational Drugs
MedicinePharmacology
2017English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis

Oncoscience
Cancer ResearchOncology
2014English

OA12.02 Updated Antitumor Activity of Crizotinib in Patients With MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy